Literature DB >> 17361352

Type II error in a randomized controlled trial of appendectomy vs. antibiotic treatment of acute appendicitis.

Kjetil Søreide, Hartwig Kørner, Jon Arne Søreide.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361352     DOI: 10.1007/s00268-006-0953-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  3 in total

1.  Sample size calculations in randomised trials: mandatory and mystical.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2005 Apr 9-15       Impact factor: 79.321

2.  Incidence of acute nonperforated and perforated appendicitis: age-specific and sex-specific analysis.

Authors:  H Körner; K Söndenaa; J A Söreide; E Andersen; A Nysted; T H Lende; K H Kjellevold
Journal:  World J Surg       Date:  1997 Mar-Apr       Impact factor: 3.352

3.  Appendectomy versus antibiotic treatment in acute appendicitis. a prospective multicenter randomized controlled trial.

Authors:  Johan Styrud; Staffan Eriksson; Ingemar Nilsson; Gunnar Ahlberg; Staffan Haapaniemi; Gunnar Neovius; Lars Rex; Ibrahim Badume; Lars Granström
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

  3 in total
  3 in total

1.  Letter to the editor. Re: Conservative management of acute appendicitis.

Authors:  Luca Ansaloni; Fausto Catena; Federico Coccolini; Filippo Gazzotti; Antonio Daniele Pinna
Journal:  J Gastrointest Surg       Date:  2010-02-02       Impact factor: 3.452

Review 2.  Antibiotics versus appendectomy in the management of acute appendicitis: a review of the current evidence.

Authors:  Gerard J Fitzmaurice; Billy McWilliams; Hisham Hurreiz; Emanuel Epanomeritakis
Journal:  Can J Surg       Date:  2011-10       Impact factor: 2.089

3.  The role of high-mobility group box-1 (HMGB-1) in the management of suspected acute appendicitis: useful diagnostic biomarker or just another blind alley?

Authors:  Kjetil Søreide
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-04-20       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.